Mirum Pharmaceuticals, Inc. (MIRM)

NGM – Real Time Price. Currency in USD

106.88

+0.71 (0.67%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

521M

337M

186M

77M

Cost of goods sold

-101M

-82M

-47M

-13M

Gross Profit

421M

255M

139M

64M

Operating expenses (excl. COGS)

-443M

-342M

-248M

-196M

Operating Income

-22M

-88M

-109M

-131M

Non-operating income, total

709K

694K

-53M

-11M

Pretax income

-21M

-87M

-162M

-142M

Equity in earnings

Taxes

-2M

-1M

-991K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-23M

-88M

-163M

-136M

Mirum Pharmaceuticals, Inc. (MIRM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Mirum Pharmaceuticals, Inc. (MIRM)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Mirum Pharmaceuticals, Inc. (MIRM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Mirum Pharmaceuticals, Inc. (MIRM)

Income Statement (Annual)

Income Statement (Annual)